Jensen R, Page DL. Epithelial hyperplasia In: Elston CW, Ellis IO, (eds). The Breast 3rd edn. Churchill Livingstone: Edinburgh, UK, 1998, pp 65–89.
Page DL, Dupont WD, Rogers LW et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698–2708.
Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990;65:518–529.
Page DL, Dupont WD, Rogers LW et al. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197–1200.
Page DL, Dupont WD, Rogers LW et al. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982;49:751–758.
Sanders ME, Schuyler PA, Dupont WD et al. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005;103:2481–2484.
Lester SC, Bose S, Chen YY et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 2009;133:15–25.
Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146–151.
Hartmann LC, Sellers TA, Frost MH et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229–237.
Marshall LM, Hunter DJ, Connolly JL et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6:297–301.
Shaaban AM, Sloane JP, West CR et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol 2002;26:421–430.
Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Churchill Livingstone: Edinburgh, London, UK; Melbourne, Australia; and New York, USA, 1987.
Elston CW, Ellis IO. The Breast 3rd edn. Churchill Livingstone: Edinburgh, London, UK; New York, Philadelphia, SanFrancisco, USA; Sidney, Australia; Toronto, Canada, 1998.
Page DL. Special types of invasive breast cancer, with clinical implications. Am J Surg Pathol 2003;27:832–835.
Dupont WD. Statistical modeling for biomedical researchers: a simple introduction to the analysis of complex data 2nd edn. Cambridge University Press: Cambridge, UK, 2009.
Betsill WL Jr., Rosen PP, Lieberman PH et al. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 1978;239:1863–1867.
Rosen PP, Braun DW Jr., Kinne DE. The clinical significance of pre-invasive breast carcinoma. Cancer 1980;46:919–925.
Collins LC, Tamimi R, Baer H et al. Risk of invasive breast cancer in patients with ductal carcinoma in situ [DCIS] treated by diagnostic biopsy alone:results from the Nurses' Health Study. Breast Cancer Res Treat 1994;88:1083.
Ernster VL, Barclay J, Kerlikowske K et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913–918.
Glover JA, Bannon FJ, Hughes CM et al. Increased diagnosis and detection rates of carcinoma in situ of the breast. Breast Cancer Res Treat 2012;133:779–784.
Hughes LL, Wang M, Page DL et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27:5319–5324.
Bijker N, Peterse JL, Duchateau L et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263–2271.
Fisher ER, Dignam J, Tan-Chiu E et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999;86:429–438.
Lagios MD, Margolin FR, Westdahl PR et al. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618–624.
Schwartz GF, Finkel GC, Garcia JC et al. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 1992;70:2468–2474.
Silverstein MJ, Lagios MD, Groshen S et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999;340:1455–1461.
Bellamy CO, McDonald C, Salter DM et al. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993;24:16–23.
Bijker N, Meijnen P, Peterse JL et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24:3381–3387.
Formenti SC, Arslan AA, Pike MC. Re: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103:1723.
Wapnir IL, Dignam JJ, Fisher B et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103:478–488.
Correa C, McGale P, Taylor C et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010:162–177.
Lee DY, Lewis JL, Wexelman BA et al. The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ. Am J Surg 2013;206:790–797.
Guerra LE, Smith RM, Kaminski A et al. Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ. Am J Surg 2008;196:552–555.
Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992;23:1095–1097.
Vandenbussche CJ, Khouri N, Sbaity E et al. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively. Am J Surg Pathol 2013;37:913–923.
Kong I, Narod SA, Taylor C et al. Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis. Curr Oncol 2014;21:e96–e104.